Aspen Pharmacare Net Income 2017-2023 | APNHY
Aspen Pharmacare annual/quarterly net income history and growth rate from 2017 to 2023. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
- Aspen Pharmacare net income for the quarter ending June 30, 2023 was $M, a NAN% increase year-over-year.
- Aspen Pharmacare net income for the twelve months ending June 30, 2023 was $0M, a NAN% increase year-over-year.
- Aspen Pharmacare annual net income for 2023 was $0.295B, a 30.93% decline from 2022.
- Aspen Pharmacare annual net income for 2022 was $0.427B, a 36.24% increase from 2021.
- Aspen Pharmacare annual net income for 2021 was $0.313B, a 4.32% increase from 2020.
Aspen Pharmacare Annual Net Income
(Millions of US $) |
| 2023 |
$295 |
| 2022 |
$427 |
| 2021 |
$313 |
| 2020 |
$300 |
| 2019 |
$456 |
| 2018 |
$469 |
| 2017 |
$375 |
| 2016 |
$298 |
| 2015 |
$ |
Aspen Pharmacare Quarterly Net Income
(Millions of US $) |
| 2023-06-30 |
|
| 2022-12-31 |
|
| 2022-06-30 |
|
| 2021-12-31 |
|
| 2021-06-30 |
|
| 2020-12-31 |
|
| 2020-06-30 |
|
| 2019-06-30 |
|
| 2018-12-31 |
|
| 2018-06-30 |
|
| 2017-12-31 |
|
| 2017-06-30 |
|
| 2016-12-31 |
|
| 2016-06-30 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Generic Drugs |
$5.038B |
$2.296B |
|
Aspen Pharmacare Holdings Limited provide specialty, branded and generic pharmaceuticals for acute and chronic conditions. It operates primarily in Sub-Saharan Africa, Latin America, South East Asia and Eastern Europe. Aspen Pharmacare Holdings Limited is headquartered in Durban, South Africa.
|
